From artificial intelligence and digital therapeutics to the latest in oncological research and RNA therapeutics, from developments in the CNS field to what’s what in customer experience an
One of the pioneers of the prescription digital therapeutics (DTx) sector, Akili Interactive, has decided to abandon that approach and focus exclusively on a direct-to-con
Why do the same medications work well in some patients and poorly in others? One reason might be the poorly understood connection between mind and body.
US non-profit the Peterson Centre on Healthcare has launched a new institute, backed with $50 million in funding, that will take a close look at the clinical benefits and
As DTx Europe came to a close at the British Medical Association in London, pharmaphorum web editor Nicole Raleigh spoke with Digital Medicine Society (DiMe) program lead, Alex Despotovic,
AstraZeneca easily delivered on chief executive Pascal Soriot’s pledge to deliver $45 billion in revenues by 2023, set a decade earlier as he fended off a takeover bid by
It’s 2024, and in most clinical trials, data is still being moved from the EHR to the EDC manually – with employees reading data from one screen and typing it onto another.